From: The interactions of novel mononuclear platinum-based complexes with DNA
Compounda | ICLE (%) | Drug concentration at 50% dsDNA retention (μM) | rb (drug: nucleotide) at 50% dsDNA retention | Last detected data point (μM) |
---|---|---|---|---|
Cisplatin | 6.8 ± 0.5 | 0.09 ± 0.01 | 1.9 × 10− 3 ± 1.4 × 10− 4 | 10 |
[Pt(RR-DACH)Cl2] | 5.6 ± 2.1 | 0.13 ± 0.05 | 2.7 × 10− 3 ± 9.9 × 10− 4 | 3 |
[Pt(RR-DACP)Cl2] | 3.1 ± 0.3 | 0.21 ± 0.02 | 4.1 × 10− 3 ± 3.9 × 10− 4 | 30 |
[Pt(SS-DACP)Cl2] | 5.1 ± 0.2 | 0.12 ± 0.01 | 2.5 × 10− 3 ± 1.1 × 10− 4 | 3 |
[Pt(4FH)Cl2] | 0.04 ± 0.02 | 23.52 ± 8.94 | 4.7 × 10− 1 ± 1.8 × 10− 1 | 300 |